Replimune Group (REPL) News
NASDAQ: REPLHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
13.20-0.05 (-0.38%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 13.20 0.00%
REPL news summary
We found 1 recent headline mentioning Replimune Group (REPL): 0 in the past week and 1 in the past 30 days, most often from Nasdaq. For price context, REPL is down 0.38% at $13.20. The most recent story, "New FDA Drug Approvals - August 2026", was published by Nasdaq on Sep 11, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology